Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.52B |
| 2 |
Apple
AAPL
|
+$645M |
| 3 |
Amazon
AMZN
|
+$557M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$392M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$354M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.17B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$262M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| 1 | Technology | 23.15% |
| 2 | Financials | 13.74% |
| 3 | Communication Services | 10.13% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Healthcare | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Identive
INVE
$87.5M
| $123K | ﹤0.01% |
7,277
-5,820
| -44% | -$98.4K |
|
|
NGM
3027
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $123K | ﹤0.01% |
6,202
-20,367
| -77% | -$404K |
|
3028
A10 Networks
ATEN
$1.29B
| $122K | ﹤0.01% |
10,727
-43,148
| -80% | -$491K |
|
3029
KalVista Pharmaceuticals
KALV
$746M
| $122K | ﹤0.01% |
5,069
-28,214
| -85% | -$679K |
|
3030
Kezar Life Sciences
KZR
$29.1M
| $122K | ﹤0.01% |
2,239
-2,199
| -50% | -$120K |
|
3031
Clear Channel Outdoor Holdings
CCO
$661M
| $121K | ﹤0.01% |
45,954
-492,013
| -91% | -$1.3M |
|
3032
Cartesian Therapeutics
RNAC
$259M
| $121K | ﹤0.01% |
969
-1,305
| -57% | -$163K |
|
3033
Tucows
TCX
$203M
| $121K | ﹤0.01% |
1,497
-9,204
| -86% | -$744K |
|
|
RADA
3034
DELISTED
Rada Electronic Industries Ltd
RADA
| $121K | ﹤0.01% |
9,935
-20,042
| -67% | -$244K |
|
3035
Comp X International
CIX
$290M
| $120K | ﹤0.01% |
5,793
-1,168
| -17% | -$24.2K |
|
3036
Teucrium Corn Fund
CORN
$48.8M
| $120K | ﹤0.01% |
5,607
+600
| +12% | +$12.8K |
|
3037
First Western Financial
MYFW
$228M
| $120K | ﹤0.01% |
4,669
-3,620
| -44% | -$93K |
|
3038
Regis Corp
RGS
$69.1M
| $120K | ﹤0.01% |
639
-946
| -60% | -$178K |
|
|
TRIL
3039
DELISTED
Trillium Therapeutics Inc.
TRIL
| $120K | ﹤0.01% |
12,377
+9,214
| +291% | +$89.3K |
|
3040
VanEck Video Gaming and eSports ETF
ESPO
$467M
| $119K | ﹤0.01% |
1,638
+1,282
| +360% | +$93.1K |
|
3041
Construction Partners
ROAD
$7.01B
| $119K | ﹤0.01% |
3,780
-19,703
| -84% | -$620K |
|
3042
Synchronoss Technologies
SNCR
$66.8M
| $119K | ﹤0.01% |
3,699
-2,579
| -41% | -$83K |
|
|
CURO
3043
DELISTED
CURO Group Holdings Corp.
CURO
| $119K | ﹤0.01% |
7,006
-12,718
| -64% | -$216K |
|
3044
Invesco S&P 500 Equal Weight Industrials ETF
RSPN
$694M
| $118K | ﹤0.01% |
+3,160
| New | +$118K |
|
3045
Arcturus Therapeutics
ARCT
$490M
| $117K | ﹤0.01% |
3,437
-30,694
| -90% | -$1.04M |
|
3046
Choiceone Financial
COFS
$457M
| $117K | ﹤0.01% |
4,844
-2,648
| -35% | -$64K |
|
3047
Evolus
EOLS
$486M
| $117K | ﹤0.01% |
9,215
-8,985
| -49% | -$114K |
|
3048
Gold Resource Corp
GORO
$114M
| $117K | ﹤0.01% |
45,138
-40,572
| -47% | -$105K |
|
3049
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$395M
| $116K | ﹤0.01% |
2,667
| – | – |
|
3050
MidCap Financial Investment
MFIC
$1.17B
| $116K | ﹤0.01% |
8,525
-1,934
| -18% | -$26.3K |
|